May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Wide–Field FLuorescein Angiography in the Management of Active ROP
Author Affiliations & Notes
  • H.D. Lam
    van Wyck–Dalany Childrens Retina Center, Childrens Hospital Los Angeles and Doheny Retina Institute, University of Southern California, Keck School of Medicine, Los Angeles, CA
  • K.A. Tawansy
    van Wyck–Dalany Childrens Retina Center, Childrens Hospital Los Angeles and Doheny Retina Institute, University of Southern California, Keck School of Medicine, Los Angeles, CA
  • H. Lee
    van Wyck–Dalany Childrens Retina Center, Childrens Hospital Los Angeles and Doheny Retina Institute, University of Southern California, Keck School of Medicine, Los Angeles, CA
  • Footnotes
    Commercial Relationships  H.D. Lam, None; K.A. Tawansy, None; H. Lee, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4092. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      H.D. Lam, K.A. Tawansy, H. Lee; Wide–Field FLuorescein Angiography in the Management of Active ROP . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4092.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the potential clinical utility of wide–angle fluorescein angiography in the setting of active ROP and uncertainty in disease manifestations. Methods: Review of a consecutive series of 30 patients with atypical disease managed at a referral center and having fluorescein angiography in their work up. Sodium fluorescein 5% was given 0.08 cc/kg body weight intra–venous and serial images were obtained with the RetCam system. Results: Fluorescein angiography was found helpful in the following situations: 1) Detection of flat neovascularization, 2) Delineating the anterior extent of retinal vascular development, 3) Detection of laser skip regions, 4) Qualitative assessment of anterior and posterior vascular activity, 5) Detection of sub–clinical retinal detachment, 6) Demonstration of arterial–venous anastamosis or capillary non–perfusion, 7) Detection of translucent neovascularization 8) Monitoring disease progression in the presence of vitreous hemorrhage and 9) Staining of the posterior vitreous to facilitate its surgical removal. It was felt to be a significant aid when threshold disease did not fully respond to laser or when atypical vascular features were present. Conclusions: Fluorescein angiography using modern imaging systems has the potential of assisting the diagnosis and management of atypical ROP.

Keywords: retinopathy of prematurity • imaging/image analysis: clinical • retinal development 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×